A carregar...
Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations
Dihydroergotamine (DHE) is an ergot alkaloid derivative of substances produced by rye fungus. Ergotamine was first used in the field of gynecology and obstetrics, then used for migraine treatment a few years later. DHE was developed as a derivative of ergotamine. DHE, when compared to ergotamine, de...
Na minha lista:
| Publicado no: | J Pain Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7200221/ https://ncbi.nlm.nih.gov/pubmed/32431533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S203650 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|